Search Results - "Thiébaud, D"

Refine Results
  1. 1

    Évolution du nombre de passages aux urgences pour intoxications aiguës lors des périodes de confinement de Covid-19 en Bourgogne-Franche-Comté by Seydou, A., Hachelaf, M., Thiébaud, D., Barondeau-Leuret, A.

    Published in Annales françaises de médecine d'urgence (01-07-2022)
    “…Objectif : Estimer l’évolution du nombre de passages aux urgences pour intoxications aiguës (IA) lors des périodes de confinement en 2020 par rapport à l’année…”
    Get full text
    Journal Article
  2. 2

    Effect of supplementation with vitamin D3 and calcium on quantitative ultrasound of bone in elderly institutionalized women : A longitudinal study by KRIEG, M. A, JACQUET, A. F, BREMGARTNER, M, CUTTELOD, S, THIEBAUD, D, BURCKHARDT, P

    Published in Osteoporosis international (01-06-1999)
    “…Supplementation of elderly institutionalized women with vitamin D and calcium decreased hip fractures and increased hip bone mineral density. Quantitative…”
    Get full text
    Journal Article
  3. 3

    Quantitative ultrasound of bone in institutionalized Elderly women : A cross-sectional and longitudinal study by KRIEG, M. A, THIEBAUD, D, BURCKHARDT, P

    Published in Osteoporosis international (01-01-1996)
    “…Quantitative ultrasound of bone is a promising method for bone assessment: radiation-free, portable and predictive of hip fracture. Its portability allowed us…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Two years' effectiveness of intravenous pamidronate (APD) versus oral fluoride for osteoporosis occurring in the postmenopause by Thiébaud, D, Burckhardt, P, Melchior, J, Eckert, P, Jacquet, A F, Schnyder, P, Gobelet, C

    Published in Osteoporosis international (01-03-1994)
    “…Bisphosphonates seem to be effective as antiresorptive agents in the prevention and treatment of osteoporosis. However, the optimal dose and route of…”
    Get full text
    Journal Article
  6. 6

    The diagnostic value of urinary pyridinium cross-links of collagen, serum total alkaline phosphatase, and urinary calcium excretion in neoplastic bone disease by Pecherstorfer, M, Zimmer-Roth, I, Schilling, T, Woitge, H W, Schmidt, H, Baumgartner, G, Thiébaud, D, Ludwig, H, Seibel, M J

    “…Bone metastases strongly affect skeletal metabolism by both their growth and their paracrine activities. However, so far no specific laboratory marker has been…”
    Get more information
    Journal Article
  7. 7

    Three monthly intravenous injections of ibandronate in the treatment of postmenopausal osteoporosis by Thiébaud, D, Burckhardt, P, Kriegbaum, H, Huss, H, Mulder, H, Juttmann, J R, Schöter, K H

    Published in The American journal of medicine (01-10-1997)
    “…Oral treatment of osteoporosis with bisphosphonates relies on compliance, the absorption being low and suppressed by simultaneous food intake. Intravenous (IV)…”
    Get more information
    Journal Article
  8. 8
  9. 9

    A 3-year study of prevention of postmenopausal bone loss: conjugated equine estrogens plus medroxyprogesterone acetate versus tibolone by Bigler, D. Thiébaud J. M., Renteria, S., Pache, T., Welti, H. J., Landry, M., Burckhardt, P.

    “…The aim of this study was to investigate the effects of tibolone in the prevention of postmenopausal bone loss over 3 years, and to compare these with the…”
    Get full text
    Journal Article
  10. 10

    An in vitro and in vivo study of cytokines in the acute-phase response associated with bisphosphonates by Thiébaud, D, Sauty, A, Burckhardt, P, Leuenberger, P, Sitzler, L, Green, J R, Kandra, A, Zieschang, J, Ibarra de Palacios, P

    Published in Calcified tissue international (01-11-1997)
    “…We studied the acute phase response, including specific cytokine production, [interleukin-1 (IL-1), interleukin-6 (IL-6), tumor necrosis factor alpha(TNF…”
    Get full text
    Journal Article
  11. 11

    Plicamycin and pamidronate in symptomatic tumor-related hypercalcemia: a prospective randomized crossover trial by Thürlimann, B, Waldburger, R, Senn, H J, Thiébaud, D

    Published in Annals of oncology (01-09-1992)
    “…We have conducted a randomized crossover comparative trial of a single-dose course of disodium (3-amino-1-hydroxypropylidene) bisphosphonate pentahydrate…”
    Get more information
    Journal Article
  12. 12

    Regulation of collagen type I and biglycan mRNA levels by hormones and growth factors in normal and immortalized osteoblastic cell lines by Thiébaud, D., Guenther, H.L., Porret, A., Burckhardt, P., Fleisch, H., Hofstetter, W.

    Published in Journal of bone and mineral research (01-09-1994)
    “…Growth factors, such as transforming growth factor β (TGF‐β) and insulin‐like growth factors (IGF) I and II, have been shown to exert anabolic effects on bone…”
    Get full text
    Journal Article
  13. 13

    Treatment of bone metastases from breast cancer and myeloma with pamidronate by Thiébaud, D, Leyvraz, S, von Fliedner, V, Perey, L, Cornu, P, Thiébaud, S, Burckhardt, P

    Published in European journal of cancer (1990) (1991)
    “…28 patients with progressing painful bone metastases (18 breast cancer, 9 myeloma and 1 low grade lymphoma) received pamidronate 60 mg by 24 h continuous…”
    Get more information
    Journal Article
  14. 14

    A single infusion of the bisphosphonate AHPrBP (APD) as treatment of Paget's disease of bone by Thiébaud, D, Jaeger, P, Gobelet, C, Jacquet, A F, Burckhardt, P

    Published in The American journal of medicine (01-08-1988)
    “…Disabling pain, skeletal deformity, or risk of joint involvement characterize Paget's disease of bone. Because the disease often affects the elderly, for whom…”
    Get more information
    Journal Article
  15. 15

    Paget's disease of bone treated in five days with AHPrBP (APD) per Os by Thiébaud, D., Jaeger, P., Burckhardt, P.

    Published in Journal of bone and mineral research (01-02-1987)
    “…Amino‐hydroxypropylidene bisphosphonic acid (AHPrBP, previously APD) is a potent inhibitor of bone resorption. Since it remains in bone for a long time, and…”
    Get full text
    Journal Article
  16. 16

    A single‐day treatment of tumor‐induced hypercalcemia by intravenous amino‐hydroxypropylidene bisphosphonate by Thiébaud, D., Jaeger, P., Jacquet, A.F., Burckhardt, P.

    Published in Journal of bone and mineral research (01-12-1986)
    “…Twenty patients with malignant hypercalcemia were treated with amino‐hydroxypropylidene bisphosphonate (AHPrBP, previously APD), a potent inhibitor of…”
    Get full text
    Journal Article
  17. 17

    Intravenous pamidronate as treatment for osteoporosis after heart transplantation : A prospective study by KRIEG, M. A, SEYDOUX, C, SANDINI, L, GOY, J. J, BERGUER, D. Gillard, THIEBAUD, D, BURCKHARDT, P

    Published in Osteoporosis international (01-02-2001)
    “…Fractures due to osteoporosis are one of the major complications after heart transplantation, occurring mostly during the first 6 months after the graft, with…”
    Get full text
    Journal Article
  18. 18
  19. 19

    Effectiveness of salmon calcitonin administered as suppositories in tumor-induced hypercalcemia by Thiébaud, D, Burckhardt, P, Jaeger, P, Azria, M

    Published in The American journal of medicine (01-04-1987)
    “…Although calcitonin is a natural, nontoxic, and rapid inhibitor of bone resorption, its use in the treatment of hypercalcemia is limited because of its…”
    Get more information
    Journal Article
  20. 20

    Dose-response study of ibandronate in the treatment of cancer-associated hypercalcaemia by Ralston, S H, Thiébaud, D, Herrmann, Z, Steinhauer, E U, Thürlimann, B, Walls, J, Lichinitser, M R, Rizzoll, R, Hagberg, H, Huss, H J, Tubiana-Hulin, M, Body, J J

    Published in British journal of cancer (01-01-1997)
    “…Hypercalcaemia is an important cause of morbidity in malignant disease. We studied the efficacy and safety of intravenous ibandronate (a new, potent…”
    Get full text
    Journal Article